59 postdoctoral-heterogeneous-catalyst uni jobs at University of Cambridge in United Kingdom
Sort by
Refine Your Search
-
Fitzgerald Group, Early Cancer Institute Senior Postdoctoral Scientist Applications are invited for a Senior Postdoctoral Scientist to join the Fitzgerald Group at The Early Cancer Institute
-
A postdoctoral position is available for 3 months (in the first instance, extension possible) from 1 June 2024 to work with Florian Hollfelder at the Biochemistry Department of Cambridge University
-
to therapy, work on the impact of ovarian cancer tumour heterogeneity on its metastatic dissemination, and a project focused on investigating low-to-high grade transition in gliomas. The Hannon group is
-
of novel oxygen evolution catalysts. The work is mainly experimental. Experience in materials preparation, characterisation and electrochemical exploitation is essential. Experience with novel, non
-
of cell lineage tracing, gene-specific perturbations, organoid assays and single-cell transcriptional profiling, the aim of the project will be to define the functional heterogeneity and fate behaviour
-
and PhDs) and postdoctoral researchers Experience in translating laboratory-based research into real-world clinical benefits Enthusiastic commitment to the recruitment, teaching, training, and mentoring
-
designed to facilitate collaboration between academics from different disciplines and to act as a catalyst for new research. This is a very varied role which combines events planning and organisation
-
This postdoctoral position will support Prof. Matt Lambon Ralph's programme on the neurocomputational basis of semantic cognition and its disorders. Collaborating with colleagues in Madison
-
and PhDs) and postdoctoral researchers Experience in translating laboratory-based research into real-world clinical benefits Enthusiastic commitment to the recruitment, teaching, training, and mentoring
-
We have an opportunity for a postdoctoral Research Associate to join our team studying new mechanisms driving neurodegenerative diseases. This is a Wellcome Trust-funded post in the laboratory of Dr